Universal Clopidogrel Versus Cyp2c19-Guided Antiplatelet Therapy In Patients With Acute Coronary Syndrome - A Cost-Effectiveness Analysis
May 1, 2015, 00:00 AM
10.1016/j.jval.2015.03.120
https://www.valueinhealthjournal.com/article/S1098-3015(15)00177-1/fulltext
Section Title :
Research on Methods Studies
Section Order :
548
First Page :
A19
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)00177-1&doi=10.1016/j.jval.2015.03.120